This blog was originally published here. COVID-19 first appeared in December 2019. By March 2020, the virus was spreading around the world with increasing speed, leading the World Health Organization to declare…
Category: Patents
Pharmaceutical Counterfeiting: What is it and Current Issues with IP Regulations
What is Pharmaceutical Counterfeiting? Counterfeit goods are an age-old consequence of economic markets. These consequences are especially troubling when raising concerns about the delivery of prescription medicines that the public…
Impact of COVID-19 on Intellectual Property system in Canada
Flexibility Demonstrated by IP Offices due to COVID19: As current and prospective intellectual property (IP) owners around the world continue to find themselves in a difficult situation as a result…
US Pharma Company, Gilead Sciences, Expands Access to COVID-19 Treatment- Experts Remain Skeptical of Long-Term Demands
As healthcare systems around the world continue to struggle with managing the rates of transmission and mortality in patients with COVID-19, an announcement made in late April by Dr. Anthony…
What USMCA Ratification Means for IP in Canada
On March 13, 2020, Canada’s House of Commons and Senate both passed Bill C-4, the Canada-United States-Mexico Agreement Implementation Act (the “Act”), which received royal assent the same day. This…
Packaging is Prime Area for Delivering on Green Innovation
Every April 26, the World Intellectual Property Organization celebrates World IP Day. This year’s theme is “Innovation for a Green Future”, which celebrates how intellectual property (IP) law can support…